Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis. Powell AE, Vlacich G, Zhao ZY, McKinley ET, Washington MK, Manning HC, Coffey RJ (2014) Am J Physiol Gastrointest Liver Physiol 307(1): G16-23
    › Primary publication · 24833705 (PubMed) · PMC4080164 (PubMed Central)
  2. Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer. McKinley ET, Liu H, McDonald WH, Luo W, Zhao P, Coffey RJ, Hanks SK, Manning HC (2013) PLoS One 8(11): e80207
    › Primary publication · 24260357 (PubMed) · PMC3832668 (PubMed Central)
  3. Limits of [18F]-FLT PET as a biomarker of proliferation in oncology. McKinley ET, Ayers GD, Smith RA, Saleh SA, Zhao P, Washington MK, Coffey RJ, Manning HC (2013) PLoS One 8(3): e58938
    › Primary publication · 23554961 (PubMed) · PMC3598948 (PubMed Central)
  4. Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging. Tang D, McKinley ET, Hight MR, Uddin MI, Harp JM, Fu A, Nickels ML, Buck JR, Manning HC (2013) J Med Chem 56(8): 3429-33
    › Primary publication · 23521048 (PubMed) · PMC3648642 (PubMed Central)
  5. 3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer. McKinley ET, Smith RA, Zhao P, Fu A, Saleh SA, Uddin MI, Washington MK, Coffey RJ, Manning HC (2013) J Nucl Med 54(3): 424-30
    › Primary publication · 23341544 (PubMed) · PMC3633462 (PubMed Central)
  6. [18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier's disease. McKinley ET, Smith RA, Tanksley JP, Washington MK, Walker R, Coffey RJ, Manning HC (2012) Ann Nucl Med 26(9): 757-63
    › Primary publication · 22821337 (PubMed) · PMC3543701 (PubMed Central)
  7. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, Tantawy MN, Peterson TE, Colvin DC, Ansari MS, Nickels M, Manning HC (2012) J Nucl Med 53(2): 287-94
    › Primary publication · 22251555 (PubMed) · PMC3391587 (PubMed Central)
  8. Multispectral fluorescence imaging to assess pH in biological specimens. Hight MR, Nolting DD, McKinley ET, Lander AD, Wyatt SK, Gonyea M, Zhao P, Manning HC (2011) J Biomed Opt 16(1): 016007
    › Primary publication · 21280913 (PubMed) · PMC3041815 (PubMed Central)
  9. 18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer. McKinley ET, Bugaj JE, Zhao P, Guleryuz S, Mantis C, Gokhale PC, Wild R, Manning HC (2011) Clin Cancer Res 17(10): 3332-40
    › Primary publication · 21257723 (PubMed) · PMC3122480 (PubMed Central)
  10. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline. Buck JR, McKinley ET, Hight MR, Fu A, Tang D, Smith RA, Tantawy MN, Peterson TE, Colvin D, Ansari MS, Baldwin RM, Zhao P, Guleryuz S, Manning HC (2011) J Nucl Med 52(1): 107-14
    › Primary publication · 21149488 (PubMed) · PMC3027353 (PubMed Central)
  11. Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. Ayers GD, McKinley ET, Zhao P, Fritz JM, Metry RE, Deal BC, Adlerz KM, Coffey RJ, Manning HC (2010) J Ultrasound Med 29(6): 891-901
    › Primary publication · 20498463 (PubMed) · PMC2925269 (PubMed Central)
  12. Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. Shah C, Miller TW, Wyatt SK, McKinley ET, Olivares MG, Sanchez V, Nolting DD, Buck JR, Zhao P, Ansari MS, Baldwin RM, Gore JC, Schiff R, Arteaga CL, Manning HC (2009) Clin Cancer Res 15(14): 4712-21
    › Primary publication · 19584166 (PubMed) · PMC2819132 (PubMed Central)
  13. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Manning HC, Merchant NB, Foutch AC, Virostko JM, Wyatt SK, Shah C, McKinley ET, Xie J, Mutic NJ, Washington MK, LaFleur B, Tantawy MN, Peterson TE, Ansari MS, Baldwin RM, Rothenberg ML, Bornhop DJ, Gore JC, Coffey RJ (2008) Clin Cancer Res 14(22): 7413-22
    › Primary publication · 19010858 (PubMed) · PMC2657180 (PubMed Central)
  14. Accelerating the development of novel molecular imaging probes: a role for high-throughput screening. Manning HC, Lander A, McKinley E, Mutic NJ (2008) J Nucl Med 49(9): 1401-4
    › Primary publication · 18703594 (PubMed) · PMC2576283 (PubMed Central)